Yellow dock

Yellow Dock (Rumex crispus L.)

1. Identity and Botanical Classification

Yellow dock is an herbaceous perennial plant belonging to the genus Rumex in the Polygonaceae family. It is native to China, Turkey, North Africa, Europe, and North America. In its Latin name, the genus Rumex denotes "acid," and the species epithet crispus means "curled," which alludes to the wavy and curly leaves of this plant species and gives it the common name "curly dock" or "curled dock."

Accepted scientific name: Rumex crispus L.
Family: Polygonaceae
Common synonyms: Curled dock, Curly dock, Narrow dock, Sour dock, Yellow dock.

Rumex crispus is a hardy, herbaceous perennial native to Europe and western Asia, now naturalised in many temperate regions worldwide. It typically grows 60–120 cm (2–4 feet) tall, with a basal rosette of leaves and tall, upright flowering stems. It thrives in disturbed ground, meadows, roadsides, and pastureland, especially in poor or compacted soils. The taproot is thick and yellow-brown with a distinctive deep yellow interior; the roots are long, fleshy, and tapering, firmly anchored and capable of reaching deep into the soil.

The medicinal portion of the plant is the root, which contains a bright yellow interior that gives the plant its name. Young leaves of R. crispus are edible and are often consumed as a vegetable, especially in spring.

Common Preparations and Dosage Forms

Yellow dock is prepared as a decoction, tincture, capsules, and applied topically in ointments and creams. The fresh root is emetic and purgative. Yellow dock root is available in many different forms, including as a tea, dried ground powder, liquid extract, and more. Powdered yellow dock root has also been used as a mouthwash or toothpaste.

2. Traditional and Historical Use

European Traditions

In Europe, the herb has been used as a purgative since the time of the ancient Greeks. Dock leaves were also used to treat scrofulous sores, sore eyes, and glandular swellings. In the 19th century, practitioners of Western herbalism recommended yellow dock root for chronic skin conditions such as eczema and psoriasis, linking its use to its purported ability to cleanse the blood and support healthy liver function.

Mesoamerican Traditions

The Aztecs called it "atlinan," meaning "its mother is water," referring to the plant's preference for growing in streambeds. They also called it "axixpatlicóztic," meaning "yellow urine medicine," which referred to its use as a diuretic. In a 1629 treatise entitled Heathen Superstitions That Today Live Among the Indians Native to This New Spain, a cleric described an Aztec remedy using the herb in an enema to treat stomachache and fever. The roots and leaves were also ground and sprinkled on wounds and sores.

Native American Traditions

Historically, Native American tribes — such as the Dakota, Blackfoot, Cheyenne, Cherokee, and Navajo — used the plant topically and internally for a wide variety of uses. Topically, the leaves were used to support healing, while internally, the roots alleviated occasional constipation and helped to purify the blood. Native Americans used yellow dock herbs to treat wounds and swellings, sore muscles, kidney trouble, and jaundice.

Asian Traditions

The roots of R. crispus are used in traditional Korean medicine to treat several diseases, including diseases of the spleen, skin, and several inflammatory pathologies. Rumex crispus root has traditionally been used in Asian medicine for the treatment of hemorrhage and dermatosis.

Indian and Other Traditions

Various cultures around the world have used yellow dock for ailments ranging from cancer and tuberculosis to syphilis, leprosy, ringworm, and hemorrhoids. In India, the juice from the roots is used for toothaches, while the powdered root is used for gingivitis and as a dentifrice. The Māori of New Zealand chew the leaf and then apply it to wounds, which they claim will heal without scarring.

Eclectic and 19th-Century Western Herbalism

Traditionally, R. crispus has been used in various countries as an astringent, laxative, diuretic, mild tonic, blood cleanser, spasmolytic, and cholagogue agent. Historically, the plant has been used to treat a variety of problems, including constipation and diarrhea, dermatitis, and venereal diseases. Folk remedies often paired yellow dock with other cleansing herbs, such as burdock and sarsaparilla, to amplify its purported detoxifying effects and support overall vitality.

3. Key Constituents and Active Compounds

Approximately 224 constituents have been isolated and identified from R. crispus, including anthraquinones, naphthalene derivatives, flavonoids, essential oil, coumarins, stilbenes, and others.

Anthraquinones

Fifteen compounds have been obtained from the petroleum ether and ethyl acetate fractions of R. crispus, including chrysophanol, physcion, emodin, chrysophanol-8-O-β-D-glucopyranoside, physcion-8-O-β-D-glucopyranoside, emodin-8-O-β-D-glucopyranoside, gallic acid, (+)-catechin, kaempferol, quercetin, and their glycosides. All species of the genus contain emodin, chrysophanol, and physcion, and in addition some contain aloe-emodin and others rhein or rhein-like substances. These anthraquinones occur in all plant parts, in free, O- and/or C-glycosidic forms, with the roots and fruits being the best sources.

The total anthraquinone content of the root (approximately 2%) exceeds that of medicinal rhubarb (Rheum rhaponticum; 1.4%), another member of the Polygonaceae family.

Flavonoids and Phenolic Compounds

Phytochemical analysis showed the presence of anthracene derivatives (chrysophanol; physcion; emodin; and their glycosides, rhein, nepodin, nepodin-1-O-β-D-glycoside, 1,5-dihydroxyanthraquinone, oxymethyloanthraquinone, and glucofranguline), trioxybenzoic acid, catechins, quercetin, kaempferol, and their glycosides in R. crispus plants. Compounds such as hyperin, quercetin, quercitrin, iso-orientin, avicularin, vitexin, and orientin are present and have been linked to therapeutic applications against hives, ringworm, boils, jaundice, psoriasis, eczema, scabies, itching, acne, and other skin disorders.

Tannins, Oxalates, and Minerals

Constituents include anthraquinone glycosides (chrysophanol and emodin), tannins, iron and other minerals, and oxalates (high in the leaf). Oxalates are present more in the leaves than the roots; roots are preferred for internal use to avoid this issue.

Nepodin

Nepodin is a compound isolated from Rumex crispus with demonstrated antimalarial activity in research. A study evaluating the antimalarial activity of nepodin demonstrated activity against Plasmodium falciparum in vitro and reduced parasitemia in mice.

4. Mechanisms of Action

Laxative Mechanism

The anthraquinone glycosides in yellow dock are distinctly reddish-orange compounds, giving the root its yellow colour. Once the anthraquinone glycosides reach the colon, gut bacteria break them down and the anthraquinones act directly on the gut lining to stimulate peristalsis in the bowel. These constituents also inhibit water absorption out of the bowel, creating the laxative effect. The anthraquinones do not cause irritation to the bowel mucosa, but can cause some gripping discomfort due to the peristalsis. Anthraquinones are also antiseptic, deterring the growth of pathogens in the enteric system.

Anthraquinone glycosides have a mild laxative action and are absorbed in the jejunum and hydrolyzed during absorption; they are then re-secreted back into the bowel, where they irritate and thus stimulate the intestines to undergo peristalsis. Tannins provide an astringent action on the gastrointestinal tract, acting as a gentle intestinal tonic, and are antioxidants.

Anti-inflammatory Mechanism

Results of anti-inflammatory assays showed that the ethyl acetate fraction of R. crispus root showed appreciable reductions in the levels of nitric oxide and inflammatory cytokines (TNF-α, IL-1β, and IL-6) in Raw 264.7 cells. Emodin also has antimicrobial and anti-inflammatory properties.

Antioxidant Mechanisms

Antioxidant activity was evaluated using various assays and was shown to be highest in the dichloromethane fraction (DCMF) and ethyl acetate fraction (EAF), corresponding to their high polyphenol and flavonoid contents. Anti-inflammatory tests revealed that high antioxidant activity correlated with inhibitory effects on nitric oxide (NO) production, and that the EAF also reduced the secretion of pro-inflammatory cytokines in a concentration-dependent manner.

Bone Metabolism

Water extract of R. crispus (WERC) containing emodin, chrysophanol, and physcion promotes osteoblastic mineralization by increasing the expression of transcription factors (Runx2, osterix, ATF-4, SATB2, Fra-1, and JunB) and phosphorylation of ERK. In vitro, WERC increased osteoblast mineralization by enhancing the transcription of runt-related transcription factor 2 (Runx2) and its transcriptional coactivators, and by stimulating extracellular signal-regulated kinase phosphorylation. Furthermore, WERC significantly inhibited osteoclast differentiation by suppressing the activation of the RANKL signaling pathways (MAPK and NF-κB) and by increasing inhibitory factors of nuclear factor of activated T cells cytoplasmic 1 (NFATc1).

Anticancer Mechanisms (Preclinical)

The anthraquinone-rich dichloromethane fraction of R. crispus root displayed the highest anticancer activity when evaluated in a human hepatoma cancer cell line (HepG2), in which it induced increased apoptosis mediated by p53 and caspase activation. DCMF was shown to inhibit HepG2 human hepatoma cancer cell growth and induce cellular apoptosis; this DCMF-induced apoptosis is facilitated by p53 tumor suppressor protein-mediated Bcl-2 family protein regulation and caspase family protein activation.

5. Scientific Evidence by Area of Use

There is limited chemical, pharmacological, and toxicity information available for yellow dock, and there is a lack of clinical research assessing efficacy and safety via robust randomised controlled trials. However, available research from laboratory studies of individual constituents provides support for the traditional actions, indications, and uses.

5.1 Digestive Health and Laxative Use

Traditional / clinical background: Yellow dock contains chemicals called anthraquinones (also found in the more famous herbal laxative senna), which stimulate bowel movements. For this reason, yellow dock is occasionally included in herbal laxative mixtures.

Evidence strength: The roots of yellow dock exert a laxative effect; however, research reveals no clinical data regarding the use of yellow dock to treat any condition. The mechanism is supported by preclinical pharmacological data on the anthraquinone constituents. No human clinical trials are available specifically for yellow dock root as a laxative agent.

5.2 Antimicrobial Activity

A 2022 PMC study employed untargeted metabolomics to explore the antimicrobial activity of Rumex crispus, a member of the Polygonaceae family used as a herbal remedy for bacterial infections. UPLC-MS was used to identify and quantify the known antimicrobial compound emodin, and biochemometric approaches integrated data measuring antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA). The results support the hypothesis that multiple constituents, including the anthraquinone emodin, contribute to the antimicrobial activity of R. crispus.

The results confirm previous work suggesting a role of emodin in the activity of R. crispus against MRSA. Informatics analysis supports the prediction that multiple small molecules from R. crispus work collectively to exert antimicrobial effects against MRSA. These findings are consistent with the traditional use of Rumex crispus topically as a complex mixture and suggest that such a mixture may be more effective against MRSA than a single compound alone. However, these studies are in vitro only, and should not be extrapolated directly to draw conclusions about the efficacy of R. crispus for use in humans.

Evidence strength: Preclinical (in vitro) only. No human clinical trials exist.

5.3 Anti-inflammatory and Antioxidant Activity

Studies demonstrate that R. crispus exhibits antioxidant, anti-inflammatory, antimicrobial, hepatoprotective, antidiabetic, and anticancer effects in both in vitro and in vivo studies. It is important to note that high doses of antioxidant-rich extracts, particularly those containing anthraquinones and tannins, can cause gastrointestinal discomfort such as cramping or diarrhea. Several Rumex species have demonstrated anti-inflammatory properties in both in vitro and in vivo models.

Evidence strength: Predominantly in vitro and animal models. No human clinical trial data are available directly for yellow dock's anti-inflammatory effects.

5.4 Bone Health / Anti-osteoporotic Activity

A study explored the pharmaceutical effects of water extract of Rumex crispus (WERC) on osteoblast and osteoclast differentiation, and also studied the effect of WERC on RANKL-induced trabecular bone destruction in a mouse model. HPLC analysis was used to identify three compounds (emodin, chrysophanol, and physcion) of WERC. The in vivo effect of WERC was examined using ICR mice with bone loss induced by intraperitoneal RANKL injection on days 0 and 1, and the femurs of mice were isolated for soft X-ray and Micro-CT analysis.

WERC significantly suppressed RANKL-induced trabecular bone loss by preventing microstructural deterioration. This study showed that WERC could protect against osteoporosis and suggested that the possible mechanism of WERC might be related to increased osteoblast differentiation by activating Runx2 signaling and inhibition of osteoclast differentiation by suppression of RANKL signaling.

Evidence strength: Animal and in vitro data only (2017, mouse model). No human clinical trials have examined yellow dock for bone health.

5.5 Anticancer Activity

The crude extracts and isolates of R. crispus exhibit antitumor, antimicrobial, antioxidant, anti-inflammatory, anti-osteoporotic, antidiabetic, anti-allergic, and other activities. Water-soluble compounds from Rumex crispus plants were screened for anti-proliferative and apoptotic activity against human colorectal adenocarcinoma (DLD-1) cells, and the most potent fraction with the highest cell killing and caspase fold change rates was selected for further experiments.

Evidence strength: In vitro (cell line) and some animal data only. There currently needs to be more publications on R. crispus's active compounds, the relationship between these ingredients and the pharmacological effects, and the remaining unexplored pharmacological activities. No human clinical trials exist.

5.6 Skin Conditions

The leaves of various Rumex species are traditionally used in the treatment of diverse skin and systemic conditions, which can be attributed to their rich flavonoid content. Compounds such as hyperin, quercetin, quercitrin, iso-orientin, avicularin, vitexin, and orientin are present and have been linked to therapeutic applications against hives, ringworm, boils, jaundice, psoriasis, eczema, scabies, itching, acne, and other skin disorders.

In a double-blind, placebo-controlled clinical trial, a cream made from Rumex occidentalis (a related Rumex species) was shown to be safe and effective for reducing melasma (darkening skin) in Filipinos. It should be noted that this trial used R. occidentalis, not R. crispus specifically, and the findings cannot be directly extrapolated.

Evidence strength: Traditional use is extensive; preclinical data are supportive. Direct human clinical evidence for R. crispus in skin conditions is absent.

5.7 Iron Status and Hematopoietic Support

The roots of R. crispus contain iron and are frequently used in Western herbal medicine as a cure for anaemia. While yellow dock does contain small amounts of iron, it is also believed that it helps the body to better absorb iron.

In the late 1990s, New Zealand herbalists Isla Burgess and Nickie Baillie, MD, conducted a pilot trial on the effects of several herbal and nutritional "iron tonic" protocols on various parameters of the blood related to anaemia, specifically attempting to answer whether Rumex crispus (yellow dock) had a positive effect on parameters of iron nutrition, a common assertion in textbooks of medical herbalism.

Evidence strength: Its iron content has led to its inclusion in some traditional formulations aimed at supporting iron levels, although direct clinical evidence in humans is lacking.

5.8 Antidiabetic Activity

Phytochemicals found in Rumex species have shown promising antidiabetic effects and are considered potential agents for the management of diabetes. Research on R. crispus specifically for antidiabetic effects is predominantly preclinical (in vitro and animal models); no clinical trials have been conducted in humans.

6. Body Systems Associated with Yellow Dock

• Gastrointestinal system: Medicinal actions attributed in herbal traditions include tonic, lymphatic, astringent, cooling, alterative, bitter, hepatic, cholagogue, laxative, and cathartic effects.
• Hepatobiliary system: Compounds in yellow dock root may stimulate digestive secretions and encourage healthy bile flow, which can help improve digestion and nutrient absorption.
• Integumentary system (skin): Yellow dock is especially indicated in traditional herbalism for chronic skin conditions with gastrointestinal complaints, especially psoriasis with constipation.
• Musculoskeletal system (preclinical): A 2017 study by Shin et al. identified that a water extract of yellow dock root (0.25 g/kg) given twice a day for five days could improve bone mineral density in an in vivo mouse model. The yellow dock significantly decreased trabecular bone loss by inhibiting osteoclast differentiation and increased bone mineralisation by stimulating osteoblast activity.
• Hematopoietic system: Yellow dock root is traditionally used as an iron tonic and blood builder; its role in iron absorption is biologically plausible but unconfirmed by clinical trials.
• Immune system / lymphatic: Rumex is most indicated in chronic toxic conditions with debilitation, tendency to tissue stagnation, lymphadenopathy, ulcers, and glandular enlargement according to traditional herbalism.

7. Dosage Forms and Reported Dosages

There is no clinical evidence to support specific dosage recommendations for yellow dock, and caution is warranted because of its oxalate and tannin content.

Traditionally reported dosages include:

• 2 to 4 tablespoons of the fresh root, or 2 to 4 g of the dry root in a tea three times a day for no longer than 8 to 10 days.
• Typical doses of yellow dock root are reported as 2 to 4 grams of dried root, 2 to 4 milliliters (ml) of liquid extract, or 1 to 2 ml of tincture.
• In a 2017 in vivo mouse model study, a water extract of yellow dock root at 0.25 g/kg was given twice a day for five days.

Yellow dock root is available in many different forms, including as a tea, dried ground powder, liquid extract, and more. Each of these forms contains different amounts of the chemicals that are naturally found in the plant.

8. Safety Considerations and Interactions

General Safety Profile

Yellow dock is generally considered safe when used appropriately in moderate amounts. However, it may cause gastrointestinal irritation in some individuals, especially at high doses. Common side effects may include loose stools, diarrhea, or an upset stomach.

Oxalate Toxicity

The raw (uncooked) leaves and stems of yellow dock contain chemicals called oxalates that may burn the mouth, throat, and stomach if taken in large amounts, and they may also cause kidney stones. Most dietary supplements and teas that contain yellow dock are made from the roots of the plant, which do not contain large amounts of oxalates.

Consuming excessive quantities of oxalic acid can cause severe toxic symptoms, including vomiting and abdominal pain, and in extreme cases, kidney stones or kidney failure. One case of fatal yellow dock poisoning has been documented. The victim, who had diabetes, ingested 1 kilogram of the raw herb in a salad and died of liver and kidney failure. The liver failure was not explained.

Cooking the leaves in water before consumption will remove excess oxalates. Spinach, Swiss chard, black tea, coffee, cocoa, nuts, seeds, and other green vegetables all similarly contain oxalates.

Contraindications

Yellow dock is contraindicated in irritable bowel, bowel obstructions, spastic colon, and pregnancy. Due to its oxalate and tannin content, yellow dock products should not be consumed in patients with endometriosis, hemorrhoids, intestinal obstruction, abdominal pain of unknown origin, or nephropathy.

Due to the anthraquinone content and strong laxative action, yellow dock should be avoided in pregnancy.

High doses can cause dermatitis, nausea, and should be avoided in those with gout or a predisposition to kidney stones (due to high oxalates).

Drug Interactions

If used excessively, yellow dock may increase potassium loss, creating a potential interaction with diuretic thiazides. Yellow dock can enhance the effects of other laxatives; dosage should be monitored carefully in combination.

Thrombocytopenia (Case Report)

A case report describes a 38-year-old African-American woman who presented with symptomatic thrombocytopenia, with a platelet count of 5 K/µl, one week after she had consumed herbal tea containing Rumex crispus (yellow dock) and Arctium lappa (burdock). The patient's platelet count improved after a course of glucocorticoids and the discontinuation of the suspected agents. As per the authors' literature review, no cases of immune thrombocytopenia caused by burdock and yellow dock had been previously published, making this case report the first to describe this possible association. Herbal medications are commonly used worldwide, yet the adverse effects are under-reported or under-recognized.

A 2024 comprehensive review notes that R. crispus is associated with adverse effects including allergenic reactions and symptomatic thrombocytopenia.

Regulatory and Approval Status

The FDA has not reviewed yellow dock for safety and effectiveness. Yellow dock root has no established medical uses, and no clinical studies exist confirming efficacy for any indication.

9. Summary of Evidence Quality

Contemporary studies have found that R. crispus possesses a wealth of chemical constituents and pharmacological activities with great promise for research, exhibiting remarkable promise particularly in its anti-inflammatory, anti-tumor, and anti-osteoporotic properties. Nonetheless, yellow dock has a long history of use in traditional herbal medicine, primarily for digestive health, liver support, and detoxification; while modern herbalists still utilize it for similar purposes, scientific evidence on its clinical effectiveness is limited. The overwhelming preponderance of pharmacological data derives from in vitro studies and animal models. Despite its historical usage, there are no established medical uses for yellow dock, and clinical studies validating its effectiveness are lacking.

References

• Qian H et al. "Rumex crispus L.: A comprehensive review on botany, traditional uses, phytochemistry, pharmacology, and safety." International Immunopharmacology, 2024. ScienceDirect.
• Pelzer CV et al. "More Than Just a Weed: An Exploration of the Antimicrobial Activity of Rumex crispus using a Multivariate Data Analysis Approach." PMC/Planta Medica, 2022.
• Eom T, Kim E, Kim JS. "In Vitro Antioxidant, Antiinflammation, and Anticancer Activities and Anthraquinone Content from Rumex crispus Root Extract and Fractions." Antioxidants (Basel), 2020. PMC.
• Shim KS, Lee B, Ma JY. "Water extract of Rumex crispus prevents bone loss by inhibiting osteoclastogenesis and inducing osteoblast mineralization." BMC Complementary and Alternative Medicine, 2017. PMC.
• Vasas A et al. "The genus Rumex (Polygonaceae): an ethnobotanical, phytochemical and pharmacological review." Natural Products and Bioprospecting, 2022. PMC.
• Kowalczyk M et al. "Variation in Phenolic Compounds Content and Antioxidant Activity of Different Plant Organs from Rumex crispus L. and Rumex obtusifolius L. at Different Growth Stages." Plants, 2019. PMC.
• Rumex Species: Phytochemistry, Pharmacology and Nutritional Potential for Food and Health Applications. PMC, 2025.
• Latif A et al. "Herbal Teas and Thrombocytopenia: A Curious Case of Yellow Dock and Burdock-Induced Thrombocytopenia." European Journal of Case Reports in Internal Medicine, 2022. PMC.
• Phytochemical Composition, Antioxidant, Antiacetylcholinesterase, and Cytotoxic Activities of Rumex crispus L. PMC, 2021.
• Potential of natural medicines for treatment of osteoporosis: a narrative review. PMC, 2023.
• Studies on the chemical constituents of Rumex crispus. PubMed, 2010.
• Yellow Dock Uses, Benefits and Dosage. Drugs.com (medically reviewed August 18, 2025).
• Yellow Dock's Therapeutic Uses. EBSCO Research Starters: Complementary and Alternative Medicine.
• Yellow Dock (Rumex crispus): Benefits, Safety, Uses. Herbal Reality, 2026.
• Yellow Dock Benefits and Uses. WholisticMatters, 2024.
• Vasas A, Orbán-Gyapai O, Hohmann J. "The Genus Rumex: Review of traditional uses, phytochemistry and pharmacology." Journal of Ethnopharmacology, 2015.
• Chemotaxonomy of anthraquinones in Rumex. Phytochemistry, ScienceDirect.
• Rumex crispus and Serum Iron. MedHerb Materia Medica.
• Yellow Dock (Rumex crispus) – Liver, Skin and Digestive Support Herb. The Herbal Medic.